Free Trial
ASX:GSS

Genetic Signatures (GSS) Stock Price, News & Analysis

Genetic Signatures logo

About Genetic Signatures Stock (ASX:GSS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

Receive GSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetic Signatures and its competitors with MarketBeat's FREE daily newsletter.

GSS Stock News Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Genetic Signatures Reports Strong Sales Boost Amid U.S. Expansion
See More Headlines

GSS Stock Analysis - Frequently Asked Questions

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,626
Year Founded
N/A

Profitability

Net Income
$-17,860,000.00
Net Margins
-129.74%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$13.77 million
Book Value
A$0.28 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.05
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (ASX:GSS) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners